Biohaven Underscores Depth of Migraine Portfolio with Data from Nurtec� ODT (rimegepant) Long-Term Open Label Study and Phase 3 Zavegepant Trial at 64th Annual Scientific Meeting of the American H… | Nachricht
31 new and encore presentations, including three late-breakers and three oral presentations, spotlight robust Nurtec ODT, zavegepant and migraine HEOR [...]
Scholar Rock Holding Corporation (SRRK) Scholar Rock to Present New Apitegromab Data Including 24-Month Efficacy and Safety Data from TOPAZ Phase 2 Trial at the 2022 Annual Cure SMA Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which [...]
Scholar Rock to Present New Apitegromab Data Including 24-Month Efficacy and Safety Data from TOPAZ Phase 2 Trial at the 2022 Annual Cure SMA Conference
– 24-month apitegromab data from Phase 2 TOPAZ trial presented by Thomas Crawford, M.D. – Also presenting patient and caregiver [...]
Global Lymphoma Antibodies Market & Clinical Trials Report 2022-2028: High Unmet Clinical Needs Associated with the Disease and Emerging Product Launches
Company Logo Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "Global Lymphoma Antibodies Market & Clinical Trials Insight 2028" report [...]
Johnson & Johnson : New Imbruvica® (ibrutinib) Data in Fixed-Duration Combination Regimen Presented at EHA 2022 Shows Deep, Durable Response at Three Years in Untreated Chronic Lymphocytic Leukemia
The all-oral, once-daily combination regimen also demonstrates the potential of immune restoration in this patient population June 10, 2022 (VIENNA) [...]
New Imbruvica® (ibrutinib) Data in Fixed-Duration Combination Regimen Presented at EHA 2022 Shows Deep, Durable Response at Three Years in Untreated Chronic Lymphocytic Leukemia
today announced new and updated results from the Phase 2 CAPTIVATE study evaluating IMBRUVICA ® (ibrutinib) in combination with venetoclax [...]
Teva to Present Latest Data on AJOVY (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting
TEL AVIV, Israel & PARSIPPANY, N.J. - Teva Pharmaceuticals , a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and [...]
Real-World Data for Mental Health – Understanding Outcomes and Unlocking Pathways to More Precise Treatments
OM1 was founded by a team dedicated to the belief that participating in value-based healthcare requires a much more complete [...]
PBM Practices Under FTC Scrutiny; APCI Applauds Decision
BESSEMER, Ala., June 7, 2022 /PRNewswire/ -- American Pharmacy Cooperative, Inc. (APCI) applauds the decision by the U.S. Federal Trade [...]
Real World Evidence Solutions Market to Reach Valuation of $1,933.16 Million by 2029, with a CAGR of 12.22% | Ibm, Iqvia, Ppd, Parexel, PerkinElmer
Global Real World Evidence Solutions Market Synopsis: Market research report execution is becoming very critical for the successful businesses as [...]
Podcast Q&A: FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation
This podcast segment features the Q&A from IQVIA's May 25, 2022 webinar hosted IQVIA experts Raina Olexa, Senior Principal Scientist [...]
Japan Drug Lobby Asserts Pricing Scheme Driving Drug Crisis
For the first time in the week starting May 16th, Japan’s three major pharmaceutical trade associations joined forces to call [...]
High-income countries dominate drug ‘compassionate use’ requests, study finds
April 15 (UPI) -- Ten high-income countries globally account for the majority of requests for compassionate use of unapproved medications [...]
Podcast Q&A: Cracking the Code: When and How to Validate ICD Algorithms for RWE
This podcast segment features the Q&A from PHAR LLC's webinar from April 12, 2022 which featured experts from PHAR, Genentech, [...]
Podcast Q&A: Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
This podcast segment features the Q&A from HealthCore's webinar from April 9, 2022 which featured an expert panel of health [...]
Silverback falls on hard times, axing lead I/O candidates and laying off more than a fourth of staff
Silverback Therapeutics became the latest biotech to undertake a “strategic realignment” Thursday, revealing it would drop its two lead cancer [...]
Repurposing Generic Drugs Can Reduce Time, Cost to Develop New Treatments
Discovering new ways to use existing drugs can come about intentionally or by chance. Sometimes physicians or patients notice an [...]
A team at Penn says it has slashed Car T cell therapy manufacturing timeframe to just 24 hours
The future of CAR T cell therapy research has come a long way over the years, but scientists have still [...]
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK
Pioneering collaboration with King’s College London and South London and Maudsley NHS Foundation Trust London, UK, 24 March 2022 COMPASS [...]
Foundation of Sand
The last decade has seen an explosion of interest in and production of real world evidence (RWE). But I’m afraid there is a day of reckoning approaching.
Cell Therapy Market Expected to Expand at a Steady 2022-2030
Description The global cell therapy market size was valued at USD 8.1 billion in 2021 and is estimated to reach [...]
Controversial Alzheimer’s drug approval ignites FDA reform debate
FDA ; Chart: Axios Visuals The FDA's conditional approval of a controversial Alzheimer's drug last year has sparked heightened scrutiny [...]
United States Real-World Evidence (RWE) Solutions Market Report 2022-2028: Rising Focus Towards Personalized Healthcare, Shift Towards Value-Based Care, & Rapidly Growing Big Data in Healthcare
DUBLIN -- The "U.S. Real-World Evidence (RWE) Solutions Market Report 2022" has been added to ResearchAndMarkets.com's offering. The U.S. RWE [...]
Global Life Sciences Software market is valued at $11 Bn
BRUSSELS, Belgium, March 14, 2022 (GLOBE NEWSWIRE) -- Summary: Medi-Tech Insights: The global Life Sciences Software market is driven by [...]
Delivering Real World Data-Driven Insights: An Executive Interview with Wendy Shusko and Jason Drenning
Delivering Real World Data-Driven Insights:An Executive Interview with Wendy Shusko and Jason Drenning Wendy Shusko, President and CEO and Jason [...]